Skip to main content
Top

Open Access 09-05-2024 | Anaplastic Large Cell Lymphoma | Review

The Risk of Breast Implant-Associated Anaplastic Large Cell Lymphoma; A Systematic Review and Meta-Analysis

Authors: Ali Mohamed Elameen, Mohamed Awad AlMarakby, Tarek Ibrahim Atta, Asmaa Ali Dahy

Published in: Aesthetic Plastic Surgery

Login to get access

Abstract

Background

Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is an emerging disorder that has gained global attention throughout the past era. The present meta-analysis was performed to retrieve the risk of BIA-ALCL from population-based epidemiological studies. Factors associated with BIA-ALCL were evaluated to identify patients at higher risk of BIA-ALCL.

Methods

A systematic literature search was executed throughout 12 databases. All epidemiological studies encompassing patients with breast implants either for aesthetic or reconstructive purposes and reported the risk of BIA-ALCL were included. Studies reported the risk factors of BIA-ALCL were included.

Results

The present meta-analysis included 17 articles, encompassing 525,475 patients with breast implants. There were 254 patients with BIA-ALCL with a mean duration to the diagnosis of BIA-ALCL of 13.16 years (95% CI 11.7–14.6, P < 0.001). There were 44 patients with textured breast implants and two with smooth implants. Patients with breast implants were 28.86 times more at high risk of BI-ALCL (95% CI 3.123–266.681). The risk ranged from 0 to 1 per 1000 cases with breast implants, with a similar risk among patients seeking aesthetic and reconstructive surgeries. The risk was 0 to 1 case per 1000 cases among patients with textured breast implants. There was a significant association between the history of breast cancer and BIA-ALCL (P = 0.0016).

Conclusion

This meta-analysis confirmed the association between breast implants and ALCL. There was a similar risk of BIA-ALCL among patients with aesthetic or reconstructive surgeries. Patients with a history of breast cancer were at higher risk of BIA-ALCL.

Level of Evidence III

This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.​springer.​com/​00266.
Appendix
Available only for authorised users
Literature
1.
go back to reference (2018) Cosmetic Surgery National Data Bank Statistics. Aesthetic Surgery Journal 38(Suppl. 3):1–24 (2018) Cosmetic Surgery National Data Bank Statistics. Aesthetic Surgery Journal 38(Suppl. 3):1–24
2.
go back to reference Gupta V, Yeslev M, Winocour J, Bamba R, Rodriguez-Feo C, Grotting JC, Higdon KK (2017) Aesthetic breast surgery and concomitant procedures: incidence and risk factors for major complications in 73,608 cases. Aesthetic Surg J 37(5):515–527CrossRef Gupta V, Yeslev M, Winocour J, Bamba R, Rodriguez-Feo C, Grotting JC, Higdon KK (2017) Aesthetic breast surgery and concomitant procedures: incidence and risk factors for major complications in 73,608 cases. Aesthetic Surg J 37(5):515–527CrossRef
3.
go back to reference American Society of Plastic Surgeons (2020) Plastic surgery statistics report American Society of Plastic Surgeons (2020) Plastic surgery statistics report
4.
go back to reference Collett DJ, Rakhorst H, Lennox P, Magnusson M, Cooter R, Deva AK (2019) Current risk estimate of breast implant–associated anaplastic large cell lymphoma in textured breast implants. Plast Reconstruct Surg 143(3S):30S-40SCrossRef Collett DJ, Rakhorst H, Lennox P, Magnusson M, Cooter R, Deva AK (2019) Current risk estimate of breast implant–associated anaplastic large cell lymphoma in textured breast implants. Plast Reconstruct Surg 143(3S):30S-40SCrossRef
5.
go back to reference Marra A, Viale G, Pileri SA, Pravettoni G, Viale G, De Lorenzi F, Nolè F, Veronesi P, Curigliano G (2020) Breast implant-associated anaplastic large cell lymphoma: a comprehensive review. Cancer Treat Rev 1(84):101963CrossRef Marra A, Viale G, Pileri SA, Pravettoni G, Viale G, De Lorenzi F, Nolè F, Veronesi P, Curigliano G (2020) Breast implant-associated anaplastic large cell lymphoma: a comprehensive review. Cancer Treat Rev 1(84):101963CrossRef
6.
go back to reference Jalalabadi F, Doval AF, Neese V, Andrews E (2021) Spiegel AJ (2021) Breast implant utilization trends in USA versus Europe and the impact of BIA-ALCL publications. Plast Reconstruct Surg Global Open 9(3):e3449CrossRef Jalalabadi F, Doval AF, Neese V, Andrews E (2021) Spiegel AJ (2021) Breast implant utilization trends in USA versus Europe and the impact of BIA-ALCL publications. Plast Reconstruct Surg Global Open 9(3):e3449CrossRef
7.
go back to reference Williams DC, Seifman MA, Hunter-Smith DJ (2019) Patient related outcome measures for breast augmentation mammoplasty: a systematic review. Gland Surg 8(4):425PubMedPubMedCentralCrossRef Williams DC, Seifman MA, Hunter-Smith DJ (2019) Patient related outcome measures for breast augmentation mammoplasty: a systematic review. Gland Surg 8(4):425PubMedPubMedCentralCrossRef
8.
go back to reference Vishwanath S, Pellegrini B, Parker E, Earnest A, Kalbasi S, Gartoulla P, Elder E, Farrell G, Moore C, Cooter RD, Ahern S (2021) Breast device surgery in Australia early results from the Australian Breast Device Registry. J Plast Reconstruct Aesthet Surg 74(10):2719–2730CrossRef Vishwanath S, Pellegrini B, Parker E, Earnest A, Kalbasi S, Gartoulla P, Elder E, Farrell G, Moore C, Cooter RD, Ahern S (2021) Breast device surgery in Australia early results from the Australian Breast Device Registry. J Plast Reconstruct Aesthet Surg 74(10):2719–2730CrossRef
9.
go back to reference Tandon VJ, DeLong MR, Ballard TN, Clemens MW, Brandt KE, Kenkel JM, Cederna PS (2018) Evolving trends in textured implant use for cosmetic augmentation in the United States. Plast Reconstruct Surg 142(6):1456–1461CrossRef Tandon VJ, DeLong MR, Ballard TN, Clemens MW, Brandt KE, Kenkel JM, Cederna PS (2018) Evolving trends in textured implant use for cosmetic augmentation in the United States. Plast Reconstruct Surg 142(6):1456–1461CrossRef
10.
go back to reference Mehdi AS, Bitar G, Sharma RK, Iyengar S, El-Sharkawi D, Tasoulis MK, Attygalle AD, Cunningham D, Sharma B, RMH BIA-ALCL Working Group (2022) Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL): A good practice guide, pictorial review, and new perspectives. Clin Radiol 77(2):79–87CrossRef Mehdi AS, Bitar G, Sharma RK, Iyengar S, El-Sharkawi D, Tasoulis MK, Attygalle AD, Cunningham D, Sharma B, RMH BIA-ALCL Working Group (2022) Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL): A good practice guide, pictorial review, and new perspectives. Clin Radiol 77(2):79–87CrossRef
12.
go back to reference Mehta-Shah N, Ghione P (2020) An updated approach and understanding of breast implant-associated anaplastic large cell lymphoma. J Natl Compr Cancer Netw 20(3):309–315CrossRef Mehta-Shah N, Ghione P (2020) An updated approach and understanding of breast implant-associated anaplastic large cell lymphoma. J Natl Compr Cancer Netw 20(3):309–315CrossRef
13.
go back to reference McKernan CD, Vorstenbosch J, Chu JJ, Nelson JA (2022) Breast implant safety: an overview of current regulations and screening guidelines. J Gen Int Med 37(1):212–216CrossRef McKernan CD, Vorstenbosch J, Chu JJ, Nelson JA (2022) Breast implant safety: an overview of current regulations and screening guidelines. J Gen Int Med 37(1):212–216CrossRef
14.
go back to reference Cunha A, Horta R, Barreiro D (2021) Epidemiological profile in Portugal of breast implant-associated anaplastic large cell lymphoma: a cross-sectional study. Acta Med Port 34(9):572–579PubMedCrossRef Cunha A, Horta R, Barreiro D (2021) Epidemiological profile in Portugal of breast implant-associated anaplastic large cell lymphoma: a cross-sectional study. Acta Med Port 34(9):572–579PubMedCrossRef
16.
go back to reference Leberfinger AN, Behar BJ, Williams NC, Rakszawski KL, Potochny JD, Mackay DR, Ravnic DJ (2017) Breast implant–associated anaplastic large cell lymphoma: a systematic review. JAMA Surg 152(12):1161–1168PubMedCrossRef Leberfinger AN, Behar BJ, Williams NC, Rakszawski KL, Potochny JD, Mackay DR, Ravnic DJ (2017) Breast implant–associated anaplastic large cell lymphoma: a systematic review. JAMA Surg 152(12):1161–1168PubMedCrossRef
17.
go back to reference Real DSS, Resendes BSA (2023) Breast implant-associated anaplastic large-cell lymphoma: a systematic literature review. Revis Brasileira de Cirurgia Plást 34:531–538 Real DSS, Resendes BSA (2023) Breast implant-associated anaplastic large-cell lymphoma: a systematic literature review. Revis Brasileira de Cirurgia Plást 34:531–538
18.
go back to reference Rohrich RJ, Kaplan J (2020) Are breast implants safe? Plast Reconstruct Surg 145(2):587–589CrossRef Rohrich RJ, Kaplan J (2020) Are breast implants safe? Plast Reconstruct Surg 145(2):587–589CrossRef
19.
go back to reference Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Int J Surg 1(88):105906CrossRef Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Int J Surg 1(88):105906CrossRef
20.
go back to reference Olsen O (2019) The guidelines on non-randomised studies. Cochrane Reviews Olsen O (2019) The guidelines on non-randomised studies. Cochrane Reviews
21.
go back to reference Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA 283(15):2008–2012PubMedCrossRef Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA 283(15):2008–2012PubMedCrossRef
22.
go back to reference National Heart, Lung and Blood Institute (2014) National Institute of Health quality assessment tool for observational cohort and cross-sectional studies. In: Bethesda: National Heart. Lung, and Blood Institute National Heart, Lung and Blood Institute (2014) National Institute of Health quality assessment tool for observational cohort and cross-sectional studies. In: Bethesda: National Heart. Lung, and Blood Institute
24.
go back to reference Duval S, Tweedie R (2000) Trim and fill: a simple funnel-plot–based method of testing and adjusting for publication bias in meta-analysis. Biometrics 56(2):455–463PubMedCrossRef Duval S, Tweedie R (2000) Trim and fill: a simple funnel-plot–based method of testing and adjusting for publication bias in meta-analysis. Biometrics 56(2):455–463PubMedCrossRef
25.
go back to reference Borenstein M (2022) Comprehensive meta-analysis software. Syst Rev Health Res Meta Anal Context 22:535–548 Borenstein M (2022) Comprehensive meta-analysis software. Syst Rev Health Res Meta Anal Context 22:535–548
26.
go back to reference Adams WP Jr, Culbertson EJ, Deva AK, Magnusson MR, Layt C, Jewell ML, Mallucci P, Hedén P (2017) Macrotextured breast implants with defined steps to minimize bacterial contamination around the device: experience in 42,000 implants. Plast Reconstruct Surg 140(3):427–431CrossRef Adams WP Jr, Culbertson EJ, Deva AK, Magnusson MR, Layt C, Jewell ML, Mallucci P, Hedén P (2017) Macrotextured breast implants with defined steps to minimize bacterial contamination around the device: experience in 42,000 implants. Plast Reconstruct Surg 140(3):427–431CrossRef
27.
go back to reference Cordeiro PG, Ghione P, Ni A, Hu Q, Ganesan N, Galasso N, Dogan A, Horwitz SM (2020) Risk of breast implant associated anaplastic large cell lymphoma (BIA-ALCL) in a cohort of 3546 women prospectively followed long term after reconstruction with textured breast implants. J Plast Reconstruct Aesthet Surg 73(5):841–846CrossRef Cordeiro PG, Ghione P, Ni A, Hu Q, Ganesan N, Galasso N, Dogan A, Horwitz SM (2020) Risk of breast implant associated anaplastic large cell lymphoma (BIA-ALCL) in a cohort of 3546 women prospectively followed long term after reconstruction with textured breast implants. J Plast Reconstruct Aesthet Surg 73(5):841–846CrossRef
28.
go back to reference Coroneos CJ, Selber JC, Offodile AC, Butler CE, Clemens MW (2019) US FDA breast implant postapproval studies: long-term outcomes in 99,993 patients. Ann Surg 269(1):30–36PubMedCrossRef Coroneos CJ, Selber JC, Offodile AC, Butler CE, Clemens MW (2019) US FDA breast implant postapproval studies: long-term outcomes in 99,993 patients. Ann Surg 269(1):30–36PubMedCrossRef
29.
go back to reference de Boer M, van Leeuwen FE, Hauptmann M, Overbeek LI, de Boer JP, Hijmering NJ, Sernee A, Klazen CA, Lobbes MB, van der Hulst RR, Rakhorst HA (2018) Breast implants and the risk of anaplastic large-cell lymphoma in the breast. JAMA Oncol 4(3):335–341PubMedPubMedCentralCrossRef de Boer M, van Leeuwen FE, Hauptmann M, Overbeek LI, de Boer JP, Hijmering NJ, Sernee A, Klazen CA, Lobbes MB, van der Hulst RR, Rakhorst HA (2018) Breast implants and the risk of anaplastic large-cell lymphoma in the breast. JAMA Oncol 4(3):335–341PubMedPubMedCentralCrossRef
30.
go back to reference Kinslow CJ, DeStephano DM, Rohde CH, Kachnic LA, Cheng SK, Neugut AI, Horowitz DP (2022) Risk of anaplastic large cell lymphoma following postmastectomy implant reconstruction in women with breast cancer and ductal carcinoma in situ. JAMA Netw Open 5(11):e2243396PubMedPubMedCentralCrossRef Kinslow CJ, DeStephano DM, Rohde CH, Kachnic LA, Cheng SK, Neugut AI, Horowitz DP (2022) Risk of anaplastic large cell lymphoma following postmastectomy implant reconstruction in women with breast cancer and ductal carcinoma in situ. JAMA Netw Open 5(11):e2243396PubMedPubMedCentralCrossRef
31.
go back to reference Largent J, Oefelein M, Kaplan H, Okerson T, Boyle P (2011) Risk of lymphoma in women with breast implants: Analysis of clinical studies. J Clin Oncol 29((15_suppl)):1588CrossRef Largent J, Oefelein M, Kaplan H, Okerson T, Boyle P (2011) Risk of lymphoma in women with breast implants: Analysis of clinical studies. J Clin Oncol 29((15_suppl)):1588CrossRef
32.
go back to reference Loch-Wilkinson A, Beath KJ, Knight RJ, Wessels WL, Magnusson M, Papadopoulos T, Connell T, Lofts J, Locke M, Hopper I, Cooter R (2017) Breast implant–associated anaplastic large cell lymphoma in Australia and New Zealand: high-surface-area textured implants are associated with increased risk. Plast Reconstruct Surg 140(4):645–654CrossRef Loch-Wilkinson A, Beath KJ, Knight RJ, Wessels WL, Magnusson M, Papadopoulos T, Connell T, Lofts J, Locke M, Hopper I, Cooter R (2017) Breast implant–associated anaplastic large cell lymphoma in Australia and New Zealand: high-surface-area textured implants are associated with increased risk. Plast Reconstruct Surg 140(4):645–654CrossRef
33.
go back to reference Loch-Wilkinson A, Beath KJ, Magnusson MR, Cooter R, Shaw K, French J, Vickery K, Prince HM, Deva AK (2020) Breast implant-associated anaplastic large cell lymphoma in Australia: a longitudinal study of implant and other related risk factors. Aesthet Surg J 40(8):838–846PubMedCrossRef Loch-Wilkinson A, Beath KJ, Magnusson MR, Cooter R, Shaw K, French J, Vickery K, Prince HM, Deva AK (2020) Breast implant-associated anaplastic large cell lymphoma in Australia: a longitudinal study of implant and other related risk factors. Aesthet Surg J 40(8):838–846PubMedCrossRef
34.
go back to reference Magnusson M, Beath K, Cooter R, Locke M, Prince HM, Elder E, Deva AK (2019) The epidemiology of breast implant–associated anaplastic large cell lymphoma in Australia and New Zealand confirms the highest risk for grade 4 surface breast implants. Plast Reconstruct Surg 143(5):1285–1292CrossRef Magnusson M, Beath K, Cooter R, Locke M, Prince HM, Elder E, Deva AK (2019) The epidemiology of breast implant–associated anaplastic large cell lymphoma in Australia and New Zealand confirms the highest risk for grade 4 surface breast implants. Plast Reconstruct Surg 143(5):1285–1292CrossRef
35.
go back to reference Maxwell GP, Van Natta BW, Bengtson BP, Murphy DK (2015) Ten-year results from the Natrelle 410 anatomical form-stable silicone breast implant core study. Aesthet Surg J 35(2):145–155PubMedPubMedCentralCrossRef Maxwell GP, Van Natta BW, Bengtson BP, Murphy DK (2015) Ten-year results from the Natrelle 410 anatomical form-stable silicone breast implant core study. Aesthet Surg J 35(2):145–155PubMedPubMedCentralCrossRef
36.
go back to reference McGuire P, Reisman NR, Murphy DK (2017) Risk factor analysis for capsular contracture, malposition, and late seroma in subjects receiving Natrelle 410 form-stable silicone breast implants. Plast Reconstruct Surg 139(1):1CrossRef McGuire P, Reisman NR, Murphy DK (2017) Risk factor analysis for capsular contracture, malposition, and late seroma in subjects receiving Natrelle 410 form-stable silicone breast implants. Plast Reconstruct Surg 139(1):1CrossRef
37.
go back to reference Nelson JA, Dabic S, Mehrara BJ, Cordeiro PG, Disa JJ, Pusic AL, Matros E, Dayan JH, Allen RJ Jr, Coriddi M, Polanco TO (2021) Breast implant-associated anaplastic large cell lymphoma incidence: determining an accurate risk. Ann Surg 272(3):403CrossRef Nelson JA, Dabic S, Mehrara BJ, Cordeiro PG, Disa JJ, Pusic AL, Matros E, Dayan JH, Allen RJ Jr, Coriddi M, Polanco TO (2021) Breast implant-associated anaplastic large cell lymphoma incidence: determining an accurate risk. Ann Surg 272(3):403CrossRef
38.
go back to reference Nelson JA, McKernan CD, Rubenstein RN, Shamsunder MG, Poulton R, Dabic S, Mehrara BJ, Disa JJ, Cordeiro PG, McCarthy CM (2023) Risk of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) in patients with temporary exposure to textured tissue expanders: an analysis of 3310 patients. Plast Reconstruct Surg 13:10–97 Nelson JA, McKernan CD, Rubenstein RN, Shamsunder MG, Poulton R, Dabic S, Mehrara BJ, Disa JJ, Cordeiro PG, McCarthy CM (2023) Risk of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) in patients with temporary exposure to textured tissue expanders: an analysis of 3310 patients. Plast Reconstruct Surg 13:10–97
39.
go back to reference Singh N, Picha GJ, Hardas B, Schumacher A, Murphy DK (2017) Five-year safety data for more than 55,000 subjects following breast implantation: comparison of rare adverse event rates with silicone implants versus national norms and saline implants. Plast Reconstruct Surg 140(4):666–679CrossRef Singh N, Picha GJ, Hardas B, Schumacher A, Murphy DK (2017) Five-year safety data for more than 55,000 subjects following breast implantation: comparison of rare adverse event rates with silicone implants versus national norms and saline implants. Plast Reconstruct Surg 140(4):666–679CrossRef
40.
go back to reference Spear SL, Murphy DK (2014) Natrelle round silicone breast implants: core study results at 10 years. Plast Reconstruct Surg 133(6):1354CrossRef Spear SL, Murphy DK (2014) Natrelle round silicone breast implants: core study results at 10 years. Plast Reconstruct Surg 133(6):1354CrossRef
41.
go back to reference Vase MØ, Friis S, Bautz A, Bendix K, Sørensen HT, d’Amore F (2013) Breast implants and anaplastic large-cell lymphoma: a Danish population-based cohort studybreast implants and anaplastic large-cell lymphoma. Cancer Epidemiol Biomark Prev 22(11):2126–2129CrossRef Vase MØ, Friis S, Bautz A, Bendix K, Sørensen HT, d’Amore F (2013) Breast implants and anaplastic large-cell lymphoma: a Danish population-based cohort studybreast implants and anaplastic large-cell lymphoma. Cancer Epidemiol Biomark Prev 22(11):2126–2129CrossRef
42.
go back to reference Wang SS, Deapen D, Voutsinas J, Lacey JV Jr, Lu Y, Ma H, Clarke CA, Weisenburger D, Forman S, Bernstein L (2016) Breast implants and anaplastic large cell lymphomas among females in the California Teachers Study cohort. Br J Haematol 74(3):480CrossRef Wang SS, Deapen D, Voutsinas J, Lacey JV Jr, Lu Y, Ma H, Clarke CA, Weisenburger D, Forman S, Bernstein L (2016) Breast implants and anaplastic large cell lymphomas among females in the California Teachers Study cohort. Br J Haematol 74(3):480CrossRef
43.
go back to reference Clemens MW, Jacobsen ED, Horwitz SM (2019) 2019 NCCN consensus guidelines on the diagnosis and treatment of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL). Aesthet Surg J 39(Supplement_1):S3–S13PubMedCrossRef Clemens MW, Jacobsen ED, Horwitz SM (2019) 2019 NCCN consensus guidelines on the diagnosis and treatment of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL). Aesthet Surg J 39(Supplement_1):S3–S13PubMedCrossRef
44.
go back to reference Rupani A, Frame JD, Kamel D (2015) Lymphomas associated with breast implants: a review of the literature. Aesthet Surg J 35(5):533–544PubMedCrossRef Rupani A, Frame JD, Kamel D (2015) Lymphomas associated with breast implants: a review of the literature. Aesthet Surg J 35(5):533–544PubMedCrossRef
45.
go back to reference U.S. Food and Drug Administration (2020) The FDA requests Allergan voluntarily recall Natrelle BIOCELL textured breast implants and tissue expanders from the market to protect patients. FDA Safety Communication, 2019 U.S. Food and Drug Administration (2020) The FDA requests Allergan voluntarily recall Natrelle BIOCELL textured breast implants and tissue expanders from the market to protect patients. FDA Safety Communication, 2019
46.
go back to reference Nava MB, Chiodini P, Catanuto G, Rocco N (2021) Is Breast Implant Associated—Anaplastic Large Cell Lymphoma linked to textured implants? Aesthet Plast Surg 45:1–9CrossRef Nava MB, Chiodini P, Catanuto G, Rocco N (2021) Is Breast Implant Associated—Anaplastic Large Cell Lymphoma linked to textured implants? Aesthet Plast Surg 45:1–9CrossRef
47.
go back to reference Gidengil CA, Predmore Z, Mattke S, van Busum K, Kim B (2015) Breast implant–associated anaplastic large cell lymphoma: a systematic review. Plast Reconstruct Surg 135(3):713–720CrossRef Gidengil CA, Predmore Z, Mattke S, van Busum K, Kim B (2015) Breast implant–associated anaplastic large cell lymphoma: a systematic review. Plast Reconstruct Surg 135(3):713–720CrossRef
48.
go back to reference Matros E, Shamsunder MG, Rubenstein RN, Polanco TO, McCarthy CM, Nelson JA, Gutowski K, Steering Committee TOPS (2021) Textured and smooth implant use reported in the tracking operations and outcomes for plastic surgeons database: epidemiologic implications for BIA-ALCL. Plast Reconstruct Surg Global Open 9(3):e3499CrossRef Matros E, Shamsunder MG, Rubenstein RN, Polanco TO, McCarthy CM, Nelson JA, Gutowski K, Steering Committee TOPS (2021) Textured and smooth implant use reported in the tracking operations and outcomes for plastic surgeons database: epidemiologic implications for BIA-ALCL. Plast Reconstruct Surg Global Open 9(3):e3499CrossRef
49.
go back to reference Becherer BE, de Boer M, Spronk PE, Bruggink AH, de Boer JP, van Leeuwen FE, Mureau MA, van der Hulst RR, de Jong D, Rakhorst HA (2019) The Dutch Breast Implant Registry: registration of breast implant–associated anaplastic large cell lymphoma—a proof of concept. Plast Reconstruct Surg 143(5):1298–1306CrossRef Becherer BE, de Boer M, Spronk PE, Bruggink AH, de Boer JP, van Leeuwen FE, Mureau MA, van der Hulst RR, de Jong D, Rakhorst HA (2019) The Dutch Breast Implant Registry: registration of breast implant–associated anaplastic large cell lymphoma—a proof of concept. Plast Reconstruct Surg 143(5):1298–1306CrossRef
50.
go back to reference Girardi JDM, Brito GV (2019) Existe associação do uso de implantes mamários texturizados com linfoma anaplásico de células grandes? Vigilância Sanitária Em Debate 7(4):85-95 Girardi JDM, Brito GV (2019) Existe associação do uso de implantes mamários texturizados com linfoma anaplásico de células grandes? Vigilância Sanitária Em Debate 7(4):85-95
51.
go back to reference Hwang K, Kim H, Kim HM, Kim JH (2021) Risk of anaplastic large-cell lymphoma (ALCL) in cases of late seroma formation after breast implant insertion. Eplast 21:e4 Hwang K, Kim H, Kim HM, Kim JH (2021) Risk of anaplastic large-cell lymphoma (ALCL) in cases of late seroma formation after breast implant insertion. Eplast 21:e4
52.
go back to reference Jabagi MJ, Goncalves A, Vey N, Le Tri T, Zureik M, Dray-Spira R (2019) Risk of hematologic malignant neoplasms after postoperative treatment of breast cancer. Cancers 11(10):1463PubMedPubMedCentralCrossRef Jabagi MJ, Goncalves A, Vey N, Le Tri T, Zureik M, Dray-Spira R (2019) Risk of hematologic malignant neoplasms after postoperative treatment of breast cancer. Cancers 11(10):1463PubMedPubMedCentralCrossRef
53.
go back to reference Wang K, Li Z, Chen X, Zhang J, Xiong Y, Zhong G, Shi Y, Li Q, Zhang X, Li H, Xiang T (2021) Risk of hematologic malignancies after breast ductal carcinoma in situ treatment with ionizing radiation. NPJ Breast Cancer 7(1):21PubMedPubMedCentralCrossRef Wang K, Li Z, Chen X, Zhang J, Xiong Y, Zhong G, Shi Y, Li Q, Zhang X, Li H, Xiang T (2021) Risk of hematologic malignancies after breast ductal carcinoma in situ treatment with ionizing radiation. NPJ Breast Cancer 7(1):21PubMedPubMedCentralCrossRef
54.
go back to reference Schubauer-Berigan MK, Daniels RD, Fleming DA, Markey AM, Couch JR, Ahrenholz SH, Burphy JS, Anderson JL, Tseng CY (2007) Risk of chronic myeloid and acute leukemia mortality after exposure to ionizing radiation among workers at four US nuclear weapons facilities and a nuclear naval shipyard. Radiat Res 167(2):222–232PubMedCrossRef Schubauer-Berigan MK, Daniels RD, Fleming DA, Markey AM, Couch JR, Ahrenholz SH, Burphy JS, Anderson JL, Tseng CY (2007) Risk of chronic myeloid and acute leukemia mortality after exposure to ionizing radiation among workers at four US nuclear weapons facilities and a nuclear naval shipyard. Radiat Res 167(2):222–232PubMedCrossRef
55.
go back to reference Gillis NK, Ball M, Zhang Q, Ma Z, Zhao Y, Yoder SJ, Balasis ME, Mesa TE, Sallman DA, Lancet JE, Komrokji RS (2017) Clonal haemopoiesis and therapy-related myeloid malignancies in elderly patients: a proof-of-concept, case-control study. Lancet Oncol 18(1):112–121PubMedCrossRef Gillis NK, Ball M, Zhang Q, Ma Z, Zhao Y, Yoder SJ, Balasis ME, Mesa TE, Sallman DA, Lancet JE, Komrokji RS (2017) Clonal haemopoiesis and therapy-related myeloid malignancies in elderly patients: a proof-of-concept, case-control study. Lancet Oncol 18(1):112–121PubMedCrossRef
56.
go back to reference Zhang B, Zhang X, Li M, Kong L, Deng X, Yu J (2016) How breast cancer chemotherapy increases the risk of leukemia: thoughts about a case of diffuse large B-cell lymphoma and leukemia after breast cancer chemotherapy. Cancer Biol Ther 17(2):125–128PubMedPubMedCentralCrossRef Zhang B, Zhang X, Li M, Kong L, Deng X, Yu J (2016) How breast cancer chemotherapy increases the risk of leukemia: thoughts about a case of diffuse large B-cell lymphoma and leukemia after breast cancer chemotherapy. Cancer Biol Ther 17(2):125–128PubMedPubMedCentralCrossRef
57.
go back to reference Krishnan B, Morgan GJ (2017) Non-Hodgkin lymphoma secondary to cancer chemotherapy. Cancer Epidemiol Biomark Prev 16(3):377–380CrossRef Krishnan B, Morgan GJ (2017) Non-Hodgkin lymphoma secondary to cancer chemotherapy. Cancer Epidemiol Biomark Prev 16(3):377–380CrossRef
Metadata
Title
The Risk of Breast Implant-Associated Anaplastic Large Cell Lymphoma; A Systematic Review and Meta-Analysis
Authors
Ali Mohamed Elameen
Mohamed Awad AlMarakby
Tarek Ibrahim Atta
Asmaa Ali Dahy
Publication date
09-05-2024
Publisher
Springer US
Published in
Aesthetic Plastic Surgery
Print ISSN: 0364-216X
Electronic ISSN: 1432-5241
DOI
https://doi.org/10.1007/s00266-024-03956-9